BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 23334144)

  • 1. 18F-fluorocholine uptake in a case of adrenal incidentaloma: possible diagnostic pitfall or potential tool for adrenocortical tumors characterization?
    Imperiale A; Cabral JF; Rust E; Flores-Turk G; Renard C; Hubele F; Detour J; Lang H; Gangi A; Namer IJ
    Clin Nucl Med; 2013 Feb; 38(2):e83-4. PubMed ID: 23334144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intense 18F-choline uptake after minor head injury: misleading PET/CT result in a patient with biochemical relapse of prostate adenocarcinoma.
    Leyendecker P; Imperiale A; Matern JF; Noël G; Namer IJ
    Clin Nucl Med; 2014 Nov; 39(11):1012-3. PubMed ID: 24999703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. False-positive result in 18F-fluorocholine PET/CT due to incidental and ectopic parathyroid hyperplasia.
    Cazaentre T; Clivaz F; Triponez F
    Clin Nucl Med; 2014 Jun; 39(6):e328-30. PubMed ID: 24152627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncocytic Adenoma of Thyroid Incidentally Detected by 18F-Fluorocholine PET/CT.
    Aziz AL; Courbon F; Dierickx LO; Pascal P; Zerdoud S
    J Nucl Med Technol; 2015 Jun; 43(2):133-4. PubMed ID: 25857420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of primary prostate cancer with dual-phase 18F-fluorocholine PET.
    Kwee SA; Wei H; Sesterhenn I; Yun D; Coel MN
    J Nucl Med; 2006 Feb; 47(2):262-9. PubMed ID: 16455632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined 18F-fluorocholine and 18F-fluoride positron emission tomography/computed tomography imaging for staging of high-risk prostate cancer.
    Kjölhede H; Ahlgren G; Almquist H; Liedberg F; Lyttkens K; Ohlsson T; Bratt O
    BJU Int; 2012 Nov; 110(10):1501-6. PubMed ID: 22502982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Single center experience of (18F)-fluorocholine positron emission tomography: analysis of its impact on salvage local therapy in patients with prostate adenocarcinoma].
    Moussaid Y; Bonardel G; Jacob J; Métivier D; Gontier E; Bauduceau O; Durand X; Fayolle M; Houlgatte A; Foehrenbach H; Védrine L; Chargari C
    Cancer Radiother; 2013; 17(4):259-64. PubMed ID: 23702489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (18)F-choline PET/CT pitfalls in image interpretation: an update on 300 examined patients with prostate cancer.
    Calabria F; Chiaravalloti A; Schillaci O
    Clin Nucl Med; 2014 Feb; 39(2):122-30. PubMed ID: 24368525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation dosimetry of 18F-fluorocholine PET/CT studies in prostate cancer patients.
    Fabbri C; Galassi R; Moretti A; Sintuzzi E; Mautone V; Sarti G; Strigari L; Benassi M; Matteucci F
    Phys Med; 2014 May; 30(3):346-51. PubMed ID: 24238928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. False-Positive 18F-PSMA-1007 and True-Negative 18F-Fluorocholine PET/CT Splenic Hemangioma.
    Panagiotidis E; Paschali A; Xourgia X; Chatzipavlidou V
    Clin Nucl Med; 2020 Dec; 45(12):960-961. PubMed ID: 33065626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of 18F-choline PET/CT in prostate cancer patients with biochemical recurrence: influence of androgen deprivation therapy and correlation with PSA kinetics.
    Beheshti M; Haim S; Zakavi R; Steinmair M; Waldenberger P; Kunit T; Nader M; Langsteger W; Loidl W
    J Nucl Med; 2013 Jun; 54(6):833-40. PubMed ID: 23559588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid lymphoma incidentally detected by 18F-fluorocholine (FCH) PET/CT.
    Eccles A; Challapalli A; Khan S; Barwick T; Mangar S
    Clin Nucl Med; 2013 Sep; 38(9):755-7. PubMed ID: 23856826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of erythropoietin on bone marrow uptake of 18F-fluorocholine in prostate cancer: comparison with 18F-fluoride uptake.
    Balogova S; Huchet V; Egrot C; Michaud L; Paycha F; Kerrou K; Montravers F; Cussenot O; Talbot JN
    Clin Nucl Med; 2013 Mar; 38(3):200-2. PubMed ID: 23354033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18F-choline PET/CT physiological distribution and pitfalls in image interpretation: experience in 80 patients with prostate cancer.
    Schillaci O; Calabria F; Tavolozza M; Cicciò C; Carlani M; Caracciolo CR; Danieli R; Orlacchio A; Simonetti G
    Nucl Med Commun; 2010 Jan; 31(1):39-45. PubMed ID: 19972635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.
    Poulsen MH; Bouchelouche K; Høilund-Carlsen PF; Petersen H; Gerke O; Steffansen SI; Marcussen N; Svolgaard N; Vach W; Geertsen U; Walter S
    BJU Int; 2012 Dec; 110(11):1666-71. PubMed ID: 22520686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of bronchioloalveolar cancer by means of PET/CT and 18F-fluorocholine, and comparison with 18F-fluorodeoxyglucose.
    Balogova S; Huchet V; Kerrou K; Nataf V; Gutman F; Antoine M; Ruppert AM; Prignon A; Lavolée A; Montravers F; Mayaud C; Cadranel J; Talbot JN
    Nucl Med Commun; 2010 May; 31(5):389-97. PubMed ID: 20145579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of pelvic lymph node metastases in patients with clinically localized prostate cancer: comparison of [18F]fluorocholine positron emission tomography-computerized tomography and laparoscopic radioisotope guided sentinel lymph node dissection.
    Häcker A; Jeschke S; Leeb K; Prammer K; Ziegerhofer J; Sega W; Langsteger W; Janetschek G
    J Urol; 2006 Nov; 176(5):2014-8; discussion 2018-9. PubMed ID: 17070241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging of prostate cancer with PET/CT and radioactively labeled choline derivates.
    Krause BJ; Souvatzoglou M; Treiber U
    Urol Oncol; 2013 May; 31(4):427-35. PubMed ID: 21388835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supraclavicular metastasis in prostate cancer detected with 18F-fluorocholine PET/CT.
    Núñez Miller R; Viera JC; Jover Díaz R; Rojo Sebastián A; Pozo MA; Alfonso Alfonso JM
    Rev Esp Med Nucl Imagen Mol; 2012; 31(1):44-6. PubMed ID: 21719158
    [No Abstract]   [Full Text] [Related]  

  • 20. Total lesion glycolysis as the best 18F-FDG PET/CT parameter in differentiating intermediate-high risk adrenal incidentaloma.
    Kim YI; Cheon GJ; Paeng JC; Cho JY; Kang KW; Chung JK; Kim EE; Lee DS
    Nucl Med Commun; 2014 Jun; 35(6):606-12. PubMed ID: 24598843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.